# Civamide Nasal Solution for Cluster Headache

> **NCT01341548** · PHASE3 · UNKNOWN · sponsor: **Winston Laboratories** · enrollment: 180 (estimated)

## Conditions studied

- Episodic Cluster Headache

## Interventions

- **DRUG:** Civamide nasal solution 0.01%

## Key facts

- **NCT ID:** NCT01341548
- **Lead sponsor:** Winston Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11
- **Primary completion:** 2025-11
- **Final completion:** 2026-02
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2021-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341548, "Civamide Nasal Solution for Cluster Headache". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01341548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*